References
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29. https://doi.org/10.3322/caac.21208
- DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252-271. https://doi.org/10.3322/caac.21235
- Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-141. https://doi.org/10.4143/crt.2015.060
- Cuschieri SA, Hanna GB. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma: let us move on to another era. Ann Surg 2014;259:e90. https://doi.org/10.1097/SLA.0000000000000418
- Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg 2011;253:900-911. https://doi.org/10.1097/SLA.0b013e318212bff6
- Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10-24. https://doi.org/10.1007/PL00011681
- Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 2010;17:3077-3079. https://doi.org/10.1245/s10434-010-1362-z
- Kim SS, Choi BY, Seo SI, Jung MY, Choi HS, Ahn SM, et al. The comparison between 6th and 7th International Union against Cancer/American Joint Committee on Cancer classification for survival prognosis of gastric cancer. Korean J Gastroenterol 2011;58:258-263. https://doi.org/10.4166/kjg.2011.58.5.258
- Kim JH, Kim CW, Choi NK, Kwak JH, Choi KM, Jang HJ, et al. The comparison between 6th and 7th UICC/AJCC N Stage for prognostic significance in gastric cancer. J Korean Surg Soc 2010;79:202-206. https://doi.org/10.4174/jkss.2010.79.3.202
- Imamura T, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Konishi H, et al. Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy. J Surg Oncol 2015;111:221-225. https://doi.org/10.1002/jso.23796
- Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 1997;4:137-140. https://doi.org/10.1007/BF02303796
- Kim DY, Seo KW, Joo JK, Park YK, Ryu SY, Kim HR, et al. Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. World J Gastroenterol 2006;12:1182-1186. https://doi.org/10.3748/wjg.v12.i8.1182
- Yokota T, Ishiyama S, Saito T, Teshima S, Yamada Y, Iwamoto K, et al. Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 2002;22:3673-3677.
- Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH, Lu YY. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. Am J Surg 2014;207:555-565. https://doi.org/10.1016/j.amjsurg.2013.05.004
- He H, Shen Z, Wang X, Qin J, Sun Y, Qin X. Survival benefit of greater number of lymph nodes dissection for advanced nodenegative gastric cancer patients following radical gastrectomy. Jpn J Clin Oncol 2016;46:63-70. https://doi.org/10.1093/jjco/hyv159
- Rausei S, Dionigi G, Ruspi L, Proserpio I, Galli F, Tirotta F, et al. Lymph node staging in gastric cancer: new criteria, old problems. Int J Surg 2013;11 Suppl 1:S90-S94. https://doi.org/10.1016/S1743-9191(13)60025-4
- Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, et al. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 2006;243:64-73. https://doi.org/10.1097/01.sla.0000194087.96582.3e
- Lee JH, Kim MG, Jung MS, Kwon SJ. Prognostic significance of lymphovascular invasion in node-negative gastric cancer. World J Surg 2015;39:732-739. https://doi.org/10.1007/s00268-014-2846-y
Cited by
- Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer: A Reminder to Pathologists to Look Harder vol.25, pp.6, 2016, https://doi.org/10.1245/s10434-018-6473-y
- The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer vol.111, pp.None, 2016, https://doi.org/10.17235/reed.2019.6041/2018
- Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification vol.21, pp.2, 2016, https://doi.org/10.1007/s12094-018-1913-5
- The Relevance of Serosal Exposure Without Nodal Metastasis in Resectional Gastric Cancer vol.26, pp.6, 2016, https://doi.org/10.1245/s10434-019-07221-1
- Retrospective evaluation of lymphatic and blood vessel invasion and Borrmann types in advanced proximal gastric cancer vol.11, pp.8, 2016, https://doi.org/10.4251/wjgo.v11.i8.642
- Meta-Analysis of Efficacy of Sijunzi Decoction Combined with Enteral Nutrition for the Treatment of Gastric Cancer vol.72, pp.5, 2016, https://doi.org/10.1080/01635581.2019.1653470
- Prognostic effect of perineural invasion in successive years in patients with locally advanced gastric cancer vol.64, pp.3, 2016, https://doi.org/10.4103/ijpm.ijpm_612_20